Home › Funds › XY Capital Ltd › TAK

XY Capital Ltd position in TAK

TAKEDA PHARMACEUTICAL CO LTD · Health Care

XY Capital Ltd reported holding 1,407,340 shares of TAK (TAKEDA PHARMACEUTICAL CO LTD) in its Q3 2026 13F filing — a position valued at US$25.6M, representing 25.05% of its reported portfolio and ranking #1 among its reported holdings. XY Capital Ltd has disclosed TAK holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.41M sh
Reported value held$25.60M
Portfolio Weight25.05%
First reportedQ3 2023
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How XY Capital Ltd's TAK position evolved

XY Capital Ltd first disclosed a stake in TAK in Q3 2023 at 143,697 shares (US$2.2M). The position peaked in Q3 2026 at 1,407,340 shares, worth US$25.6M. Across 9 filings, XY Capital Ltd increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,407,340 shares valued at US$25.6M. Notable position changes include a 432% increase in Q4 2023 (shares fell 3% over the following quarter), a 71% trim in Q1 2024 (shares fell 7% over the following quarter), a 55% increase in Q2 2024 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 143.70K $2.22M New
Q4 2023 765.14K $10.92M Add
Q1 2024 222.28K $3.09M Reduce
Q2 2024 344.05K $4.45M Add
Q3 2024 164.49K $2.34M Reduce
Q4 2024 162.70K $2.15M Reduce
Q1 2025 95.83K $1.42M Reduce
Q3 2025 200.03K $2.93M New
Q3 2026 1.41M $25.60M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TAK and 13F data

TAK (TAKEDA PHARMACEUTICAL CO LTD) is a Health Care company. 30 other funds we track also report a position in TAK — the largest reported positions include MANAGED ASSET PORTFOLIOS, LLC (US$33.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TAK

All TAK fund holders →

FAQ

How long has XY Capital Ltd held TAK?

XY Capital Ltd has disclosed TAK holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is XY Capital Ltd's current position in TAK?

As of Q3 2026, XY Capital Ltd holds 1.41M shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), valued at $25.60M, representing 25.05% of its reported portfolio and ranking #1.

Has XY Capital Ltd been buying or selling TAK?

In the latest 13F filing (Q3 2026), XY Capital Ltd newly opened its position in TAK. The position peaked in Q3 2026 at 1.41M shares.

Which other funds hold TAK?

Other major institutional holders of TAK include MANAGED ASSET PORTFOLIOS, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.